In clinical medicine, 5 mg of prednisone per day is classified as a low dose, sitting at the bottom of most dosing scales. Rheumatologists, pulmonologists, and other specialists routinely prescribe it as a long-term maintenance level, and many patients feel reassured when their doctor tapers them down to it. But the label “low dose” has created a widespread misunderstanding: that 5 mg is too small to cause real harm. The evidence tells a more complicated story, one where even this modest amount of synthetic steroid can chip away at bones, raise infection risk, and suppress your body’s own hormone production.
What “Low Dose” Means on the Clinical Scale
Doctors generally sort prednisone prescriptions into rough tiers. Low dose covers anything up to about 7.5 mg per day. Medium dose runs from 7.5 mg to roughly 30 mg. High dose is anything above that, with pulse therapy reaching 250 mg or more for acute crises. By that yardstick, 5 mg sits comfortably in the low category. It is the dose many people with rheumatoid arthritis, polymyalgia rheumatica, or lupus end up taking for months or years after their initial flare is controlled. In a prospective study of patients with polymyalgia rheumatica, for example, the average maintenance dose during the second year of treatment was about 4.3 mg of prednisolone, hovering right around the 5 mg mark that many clinicians target.1PubMed. Prednisolone maintenance dose in relation to starting dose in the treatment of polymyalgia rheumatica and temporal arteritis
The trouble is that “low” is a relative term on a scale designed primarily to manage disease activity, not to describe safety. A dose can be both low on the clinical scale and high enough to cause side effects over time. This distinction matters because patients often hear “low dose” and assume they are out of the woods. They are not.
How 5 mg Compares to What Your Body Makes Naturally
Your adrenal glands produce cortisol every day in a pulsing rhythm that peaks in the early morning and tapers through the afternoon. The total daily output in a healthy person is roughly equivalent to 15 to 25 mg of hydrocortisone, or about 3 to 5 mg of prednisolone.2PubMed Central. Daily Glucocorticoid Replacement Dose in Adrenal Insufficiency, a Mini Review Prednisone and prednisolone are roughly four to five times more potent milligram-for-milligram than hydrocortisone at suppressing the body’s stress-hormone axis, though that potency ratio shifts depending on how many hours have elapsed since the dose.3The American Journal of Medicine. Potency and duration of action of glucocorticoids: Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function
That means 5 mg of prednisone is right at the upper edge of what a healthy person’s adrenals would produce on their own. It is a physiological replacement dose for someone whose adrenal glands do not work, and a mildly supraphysiological dose for someone whose glands are still functioning. This is why the endocrine literature increasingly argues that 5 mg may already be more than many people need for simple hormone replacement. A 2023 study on optimizing prednisolone in adrenal insufficiency concluded that previous replacement doses of 5 to 7.5 mg were harmful and that most patients did well on 2 to 4 mg.4PubMed Central. Optimising prednisolone or prednisone replacement in adrenal insufficiency The implication is that if 5 mg is already considered too high for simple replacement, it is definitely exerting pharmacological effects beyond just filling in for missing cortisol.
Bone Loss Starts at Surprisingly Low Doses
The effect of prednisone on bones is one of the best-studied low-dose risks. A large meta-analysis of corticosteroid-induced osteoporosis concluded that oral corticosteroid treatment using more than 5 mg daily of prednisolone or its equivalent leads to reduced bone mineral density and a rapid increase in fracture risk during treatment.5PubMed. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis But even doses below that threshold are not entirely safe. A study of more than 200,000 oral corticosteroid users found that fracture risk was already elevated at daily prednisone-equivalent doses of 2.5 to 7.5 mg, with increased rates of both hip and vertebral fractures compared with people taking no corticosteroids at all.6Prescriber Update. Oral Steroids and Fracture
The bone damage from glucocorticoids works differently from ordinary age-related bone loss. Prednisone suppresses the cells that build new bone while activating the cells that break it down, and it also reduces calcium absorption in the gut. The result is a rapid initial drop in bone density, especially in the first year of treatment, followed by a slower ongoing decline. This is why most guidelines recommend bone-density screening and preventive measures like calcium, vitamin D, and sometimes a bone-protective medication for anyone who expects to take even 5 mg of prednisone for more than a few months.
Infection Risk Does Not Wait for High Doses
Prednisone blunts the immune system’s surveillance and response capacity, and this effect is not limited to the dramatic immunosuppression seen at high doses. Observational studies have consistently shown increased risk of serious infections, the kind requiring hospitalization or intravenous antibiotics, even at prednisone-equivalent doses of 5 mg or less daily. A large U.S. safety collaboration found that in patients with rheumatoid arthritis, corticosteroid use at less than 5 mg per day was already associated with about a 32% increase in serious bacterial infections. The risk climbed in a stepwise fashion: roughly 78% higher at 5 to 10 mg per day, and nearly threefold at doses above 10 mg.7PubMed Central. Infection Risk and Safety of Corticosteroid Use
Duration matters as much as daily dose. A Canadian study of more than 16,000 older adults with rheumatoid arthritis found that the infection risk at 5 mg per day was modest after just one week of use but doubled after three years of continuous use at the same dose.7PubMed Central. Infection Risk and Safety of Corticosteroid Use That cumulative exposure is the part most patients underestimate. A short course of 5 mg while waiting for another medication to kick in carries very different risk from taking 5 mg every day for years.
The GLORIA Trial and Real-World Tradeoffs
One of the clearest illustrations of the benefit-harm balance at 5 mg comes from the GLORIA trial, a large randomized study of older adults with rheumatoid arthritis. Patients aged 65 and older were assigned to either 5 mg of prednisolone per day or placebo on top of their usual treatment, and followed for two years. The prednisolone group had meaningfully better disease control, with lower disease-activity scores and less joint damage on X-rays. But the tradeoff was real: 60% of the prednisolone group experienced at least one adverse event over two years, compared with 49% in the placebo group. Infections accounted for much of the difference.8Annals of the Rheumatic Diseases. Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial
The trial is valuable because it captures the kind of calculus that doctors and patients face in the real world. The benefits of 5 mg were genuine and clinically meaningful for disease control. The harms were also genuine and not negligible. Neither side of the equation was trivial. For an older person with active rheumatoid arthritis who has limited other options, 5 mg might be the best available choice despite its risks. For someone whose disease is well-controlled on other medications alone, even 5 mg may be adding risk without enough benefit to justify it.
Blood Sugar and Cardiovascular Effects
One area where 5 mg appears to be somewhat safer is metabolic health. A review in Endocrine Reviews noted that while small studies have suggested glucose tolerance could be impaired at doses around 7.5 mg of prednisolone daily with prolonged use, the risk at doses below 7.5 mg was not elevated in larger analyses.9Endocrine Reviews. Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad? That does not mean 5 mg has zero metabolic impact. Some people are more sensitive than others, and anyone with pre-existing insulin resistance or borderline blood sugar should be monitored. But the threshold for clinically meaningful glucose disruption appears to sit a bit above 5 mg for most people, which is one of the few areas where the “low dose” label holds up reasonably well.
Cardiovascular risk at low doses is harder to pin down because most of the large studies lump corticosteroid users together or compare broad dose categories. A study in a prostate cancer population found that patients receiving 5 mg of prednisone twice daily (10 mg total, not the same as the 5 mg once daily we are discussing) alongside abiraterone had significantly longer times before developing hypertension or low potassium compared with a lower-dose group.10Journal of Clinical Oncology. Effect of prednisone dosing on mineralocorticoid-related side effects with abiraterone in prostate cancer That study speaks more to abiraterone’s mineralocorticoid effects than to prednisone’s cardiovascular risk on its own, but it illustrates how context-dependent the question of “low dose” really is. The same 5 mg can play very different roles depending on the underlying condition and the other drugs in the mix.
HPA Axis Suppression and Why Stopping Matters
Your body’s stress-hormone system, the hypothalamic-pituitary-adrenal axis, adjusts its output based on how much cortisol it detects in circulation. When you take exogenous prednisone, even at 5 mg, the axis senses the extra steroid and dials down its own production. Over time, the adrenal glands can atrophy from disuse. The old assumption was that this only mattered at higher doses or after many weeks, but recent evidence has shown that even low doses below 5 mg of prednisone equivalent and treatment courses shorter than four weeks can suppress the axis.11PubMed Central. Glucocorticoid Withdrawal-An Overview on When and How to Diagnose Adrenal Insufficiency in Clinical Practice
This has direct practical consequences for stopping the medication. If you have been on 5 mg for several months and abruptly stop, you may experience fatigue, muscle aches, low blood pressure, nausea, or even an adrenal crisis during physical stress. The standard recommendation is to taper slowly once you reach physiological-range doses, and to allow the axis time to recover. The rate of tapering at this stage depends on how quickly the adrenal glands wake back up, which varies from person to person. Some people recover in weeks, others take months, and a small number may need low-dose replacement indefinitely.12PubMed. Is there a safe and effective way to wean patients off long-term glucocorticoids?
People are sometimes surprised that they feel worse when they stop a medication they thought was barely doing anything. The feeling of withdrawal is not the disease coming back (though that can happen simultaneously); it is the body scrambling to restart cortisol production that prednisone had been providing. This is one more reason the “low dose” label can be misleading: the drug is deeply embedded in your hormonal regulation even at 5 mg.
Mood, Sleep, and Cognitive Effects
Corticosteroid-related mood changes are well-documented at higher doses, where mania, euphoria, irritability, and insomnia are common. At 5 mg, these effects are less dramatic but not absent. Mood and cognitive symptoms from corticosteroids are dose-dependent and tend to appear during the first few weeks of therapy. During long-term use, depression becomes more common than the manic-type reactions seen with acute high-dose courses.13PubMed. Effects of glucocorticoids on mood, memory, and the hippocampus Patients on chronic low-dose prednisone sometimes report subtle changes: mild insomnia, irritability, difficulty concentrating, or a general sense of emotional flatness. These effects are easy to attribute to the underlying illness or to aging, which is part of why they are underrecognized.
A study of long-term glucocorticoid users found that physicians significantly underestimated the frequency of neuropsychiatric side effects. Patients reported these effects about twice as often as their doctors guessed, and poor adherence to the prescribed regimen was common, with nearly two-thirds of patients described as poorly adherent.14The American Journal of Medicine. Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events The disconnect suggests that many patients are quietly struggling with side effects they either do not mention or have not connected to their prednisone.
When 5 mg Is More Than You Need
For people who take prednisone not to suppress inflammation but to replace missing cortisol, as in Addison’s disease or other forms of adrenal insufficiency, the dosing conversation looks different. Guidelines have historically recommended replacement doses equivalent to about 3 to 5 mg of prednisolone.2PubMed Central. Daily Glucocorticoid Replacement Dose in Adrenal Insufficiency, a Mini Review But newer research using blood-level monitoring suggests that most patients with adrenal insufficiency do well on 2 to 4 mg, and that the older standard of 5 to 7.5 mg was often excessive, exposing patients to unnecessary glucocorticoid load and its associated side effects.4PubMed Central. Optimising prednisolone or prednisone replacement in adrenal insufficiency
This shift in replacement dosing is worth knowing about even if you are taking prednisone for an inflammatory condition, because it signals something about the drug’s potency at the low end of the scale. If endocrinologists now consider 5 mg excessive for simple hormone replacement, it underscores that 5 mg is pharmacologically active in ways that matter.
Does Timing of the Dose Change the Risk?
Your body’s natural cortisol peaks around 6 to 8 a.m. and bottoms out overnight. Taking prednisone in the morning roughly aligns with this cycle, which is why morning dosing is standard. A modified-release formulation designed to release prednisone around 2 a.m. has been studied in rheumatoid arthritis patients, with the rationale that catching overnight inflammatory surges earlier might improve symptom control. Research showed that this nighttime-release approach did not worsen adrenal suppression compared to conventional morning dosing, and it was at least as effective for controlling morning stiffness.15PubMed Central. Circadian rhythms in rheumatology–a glucocorticoid perspective16The Journal of Rheumatology. Hypothalamus-Pituitary-Adrenal Axis Function in Patients with Rheumatoid Arthritis Treated with Nighttime-Release Prednisone
For most people taking 5 mg once daily, morning dosing remains the default. If you find that a single morning dose leaves you sleepless or jittery at night, that is worth mentioning to your doctor, but it usually reflects individual sensitivity rather than a dosing-schedule problem at this dose level.
Why Individual Responses Vary So Much
One of the more frustrating aspects of prednisone is how differently people respond to the same dose. Some patients take 5 mg for years with few obvious side effects; others gain weight, develop thin skin, and feel terrible within months. Part of this comes down to genetics. A recent study in lupus patients built a prediction model for optimal prednisone dosing and found that genetic variants in the CYP3A4 enzyme, which metabolizes prednisone in the liver, along with factors like albumin level and hemoglobin, were strongly correlated with how much drug a patient actually needed.17PubMed Central. Construction and evaluation of glucocorticoid dose prediction model based on genetic and clinical characteristics of patients with systemic lupus erythematosus
Age plays a role too. Older adults metabolize prednisone more slowly, have less bone reserve to begin with, and are more susceptible to infections and metabolic disruption. The GLORIA trial’s focus on patients 65 and older was not accidental: that is the population where the benefit-harm tradeoff of low-dose prednisone is most fraught. Body composition also matters. A smaller person taking 5 mg is getting a higher dose per kilogram of body weight than a larger person, which can shift side-effect profiles in ways that a flat milligram number does not capture.
Prednisone During Pregnancy and Breastfeeding
Pregnant women who need prednisone for autoimmune conditions face a unique pharmacokinetic situation. During pregnancy, the body clears prednisone faster than usual, and this clearance increases with dose. At 5 mg, the apparent oral clearance in pregnant women was measured at about 35 liters per hour, rising to more than 64 liters per hour at 20 mg.18PubMed Central. Prednisone Pharmacokinetics During Pregnancy and Lactation This means pregnant women may get less drug exposure from a given dose than non-pregnant adults, which sometimes leads doctors to adjust doses upward during pregnancy flares.
For breastfeeding mothers, the news is reassuring. The amount of prednisone and its active form prednisolone transferred into breast milk is minimal, with the infant receiving well under 1% of the mother’s weight-adjusted dose.18PubMed Central. Prednisone Pharmacokinetics During Pregnancy and Lactation At a maternal dose of 5 mg, the amount reaching a nursing infant is negligible by any clinical standard. This is one of the reasons rheumatologists and obstetricians are generally comfortable maintaining women on low-dose prednisone through pregnancy and lactation when the underlying disease requires it, though the decision always involves weighing both maternal disease control and fetal exposure to glucocorticoids.
What Long-Term Use at 5 mg Actually Looks Like
The cumulative picture of 5 mg over years is a slow accumulation of small risks rather than a sudden catastrophe. A study of long-term low-dose corticosteroid therapy in rheumatoid arthritis (defined as 15 mg per day or less, for more than a year) found that average daily doses of 5 to 10 mg were correlated with a more than fourfold increase in serious adverse events compared to non-users, even after accounting for disease severity.14The American Journal of Medicine. Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events The events tracked included fractures, serious infections, gastrointestinal bleeding, and cataracts. The study acknowledged that sicker patients tend to receive more prednisone, making it hard to fully untangle the drug’s effects from the disease’s effects, but the dose-response pattern was consistent.
Patients on prolonged low-dose steroids who are not experiencing acute side effects sometimes assume the drug is harmless to them personally. The reality is that some effects, like gradual bone thinning and slow changes in body composition, are largely invisible until a fracture happens or a scan reveals low bone density. Others, like subtle immune suppression, only become apparent when an infection takes longer to resolve or hits harder than expected. Proactive monitoring, regular bone-density scans, attention to blood sugar, and honest conversations about whether the prednisone is still earning its place in the regimen, are the practical tools for managing a drug that helps and harms in equal quiet measures.